Cargando…

Linkage Specific Fucosylation of Alpha-1-Antitrypsin in Liver Cirrhosis and Cancer Patients: Implications for a Biomarker of Hepatocellular Carcinoma

BACKGROUND: We previously reported increased levels of protein-linked fucosylation with the development of liver cancer and identified many of the proteins containing the altered glycan structures. One such protein is alpha-1-antitrypsin (A1AT). To advance these studies, we performed N-linked glycan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Comunale, Mary Ann, Rodemich-Betesh, Lucy, Hafner, Julie, Wang, Mengjun, Norton, Pamela, Di Bisceglie, Adrian M., Block, Timothy, Mehta, Anand
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928295/ https://www.ncbi.nlm.nih.gov/pubmed/20811639 http://dx.doi.org/10.1371/journal.pone.0012419

Ejemplares similares

Altered Functionality of Anti-Bacterial Antibodies in Patients with Chronic Hepatitis C Virus Infection
por: Lamontagne, Anne, et al.
Publicado: (2013)

Intrinsic hepatocyte dedifferentiation is accompanied by upregulation of mesenchymal markers, protein sialylation and core alpha 1,6 linked fucosylation
por: Mehta, Anand, et al.
Publicado: (2016)

Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review
por: Norton, Pamela A, et al.
Publicado: (2019)

Fucosylated forms of alpha-1-antitrypsin that predict unresponsiveness to chemotherapy in ovarian cancer.
por: Thompson, S., et al.
Publicado: (1988)

Fucosylated Glycoproteins as Markers of Liver Disease
por: Mehta, Anand, et al.
Publicado: (2008)

A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables
por: Wang, Mengjun, et al.
Publicado: (2013)

Correction: A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables
por: Wang, Mengjun, et al.
Publicado: (2013)

A Biomarker Panel Based upon AFP, Fucosylated Kininogen and PEG-Precipitated IgG Is Highly Accurate for the Early Detection Hepatocellular Carcinoma in Patients with Cirrhosis in Phase II and Phase III Biomarker Evaluation
por: Wang, Mengjun, et al.
Publicado: (2022)

Alpha 1-antitrypsin and survival in hepatocellular carcinoma.
por: Tzonou, A., et al.
Publicado: (1990)

alpha1-Antitrypsin deficiency and hepatocellular cancer.
por: Kew, M. C., et al.
Publicado: (1978)

Alpha-1-Antitrypsin in Pathogenesis of Hepatocellular Carcinoma
por: Topic, Aleksandra, et al.
Publicado: (2012)

Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans.
por: Aoyagi, Y., et al.
Publicado: (1993)

Analysis of Serum Haptoglobin Fucosylation in Hepatocellular Carcinoma and Liver Cirrhosis of Different Etiologies
por: Zhu, Jianhui, et al.
Publicado: (2014)

Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis
por: Al-Jameil, Noura, et al.
Publicado: (2017)

Alpha-1 Antitrypsin and Hepatocellular Carcinoma in Liver Cirrhosis: SERPINA1 MZ or MS Genotype Carriage Decreases the Risk
por: Rabekova, Zuzana, et al.
Publicado: (2021)

Heterozygosity for the alpha‐1‐antitrypsin Z allele in cirrhosis is associated with more advanced disease
por: Schaefer, Benedikt, et al.
Publicado: (2018)

Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin Pi∗MZ genotype
por: Chen, Vincent L., et al.
Publicado: (2022)

Clinical usefulness of alpha-1-antitrypsin in the diagnosis of hepatocellular carcinoma.
por: Hong, W. S., et al.
Publicado: (1991)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)

Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein
por: Setsu, Toru, et al.
Publicado: (2017)

Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
por: Sosulski, Meredith L., et al.
Publicado: (2020)

Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency
por: Wanner, Adam
Publicado: (2015)

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Petrache, Irina, et al.
Publicado: (2009)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
por: Chapman, Kenneth R, et al.
Publicado: (2018)

Structural characterization and conformational dynamics of alpha-1 antitrypsin pathogenic variants causing alpha-1-antitrypsin deficiency
por: Shaik, Noor Ahmad, et al.
Publicado: (2022)

Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis
por: Ogawa, Koji, et al.
Publicado: (2020)

The prevalence of alpha-1 antitrypsin deficiency in Ireland
por: Carroll, Tomás P, et al.
Publicado: (2011)

Alpha 1-antitrypsin retention in an ectopic liver
por: Dettmer, Matthias, et al.
Publicado: (2011)

Polymorphism of alpha-1-antitrypsin in hematological malignancies
por: Topic, Aleksandra, et al.
Publicado: (2009)

Alpha‐1‐antitrypsin in cell and organ transplantation
por: Berger, Mel, et al.
Publicado: (2018)

Alpha-1 Antitrypsin Deficiency: The Learning Goes On
por: Stockley, Robert. A.
Publicado: (2020)

Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
por: Belchamber, Kylie B R, et al.
Publicado: (2020)

Alpha-1 Antitrypsin Deficiency: Home Therapy
por: Annunziata, Anna, et al.
Publicado: (2021)

The unfolded protein response to PI*Z alpha‐1 antitrypsin in human hepatocellular and murine models
por: Lu, Yuanqing, et al.
Publicado: (2022)

The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients
por: Sark, Annelot D., et al.
Publicado: (2022)

Liver Cirrhosis Secondary to Autoimmune Hepatitis in a Patient with Alpha-1 Antitrypsin ZZ Phenotype: A "Double Hit" Phenomenon
por: Hoilat, Gilles J, et al.
Publicado: (2021)

Clinical utility of serum fucosylated fraction of alpha-fetoprotein in the diagnostic of hepatocellular carcinoma: a comprehensive analysis with large sample size
por: Liu, Aibin, et al.
Publicado: (2022)

alpha 1-Antitrypsin deficiency and susceptibility to lung disease.
por: Evans, H E, et al.
Publicado: (1979)

Alpha 1 Antitrypsin Deficiency in Infants with Neonatal Cholestasis
por: Monajemzadeh, Maryam, et al.
Publicado: (2013)

Alpha-1 antitrypsin genotypes in breast cancer patients
por: El-Akawi, Z, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_icnkhc8dik5neijaplsn6r78sb